Works matching IS 25233548 AND DT 2024 AND VI 44 AND IP 9

Results: 9

Immune mediated support of metastasis: Implication for bone invasion.
Published in:
Cancer Communications, 2024, v. 44, n. 9, p. 967, doi. 10.1002/cac2.12584
By:
- Xin, Zengfeng;
- Qin, Luying;
- Tang, Yang;
- Guo, Siyu;
- Li, Fangfang;
- Fang, Yuan;
- Li, Gege;
- Yao, Yihan;
- Zheng, Binbin;
- Zhang, Bicheng;
- Wu, Dang;
- Xiao, Jie;
- Ni, Chao;
- Wei, Qichun;
- Zhang, Ting
Publication type:
Article
Dysfunction of dendritic cells in tumor microenvironment and immunotherapy.
Published in:
Cancer Communications, 2024, v. 44, n. 9, p. 1047, doi. 10.1002/cac2.12596
By:
- Chen, Jie;
- Duan, Yuhang;
- Che, Junye;
- Zhu, Jianwei
Publication type:
Article
Efficacy, safety and biomarkers of SG001 for patients with previously treated recurrent or metastatic cervical cancer: an open‐label, multicenter, phase Ib trial.
Published in:
Cancer Communications, 2024, v. 44, n. 9, p. 1042, doi. 10.1002/cac2.12578
By:
- Zuo, Jing;
- Duan, Wei;
- Zhao, Mingxuan;
- Chen, Zhendong;
- Lin, Jie;
- Shi, Huaqiu;
- Jiang, Ou;
- Zhang, Youzhong;
- Fang, Meiyu;
- Wang, Li;
- Wang, Wei;
- Huang, Yong;
- Yu, Junyan;
- Zhang, Xiaoxue;
- Pu, Weiqing;
- Hao, Deshun;
- She, Fenglin;
- Yang, Xiugao;
- Chen, Ying;
- Tang, Qizhi
Publication type:
Article
Real‐world data on ALK rearrangement test in Chinese advanced non‐small cell lung cancer (RATICAL): a nationwide multicenter retrospective study.
Published in:
Cancer Communications, 2024, v. 44, n. 9, p. 992, doi. 10.1002/cac2.12593
By:
- Li, Lin;
- Li, Wencai;
- Wu, Chunyan;
- Xi, Yanfeng;
- Guo, Lei;
- Ji, Yuan;
- Jiang, Lili;
- Li, Ji;
- Yun, Jingping;
- Chen, Gang;
- Li, Yuan;
- Liu, Yueping;
- Mu, Dianbin;
- Han, Yuchen;
- Sun, Leina;
- Xia, Qingxin;
- Teng, Xiaodong;
- Che, Nanying;
- Wu, Wei;
- Qiu, Xueshan
Publication type:
Article
Advances and clinical applications of immune checkpoint inhibitors in hematological malignancies.
Published in:
Cancer Communications, 2024, v. 44, n. 9, p. 1071, doi. 10.1002/cac2.12587
By:
- Sun, Wenyue;
- Hu, Shunfeng;
- Wang, Xin
Publication type:
Article
Targeting N4‐acetylcytidine suppresses hepatocellular carcinoma progression by repressing eEF2‐mediated HMGB2 mRNA translation.
Published in:
Cancer Communications, 2024, v. 44, n. 9, p. 1018, doi. 10.1002/cac2.12595
By:
- Liu, Hailing;
- Xu, Lei;
- Yue, Shiwei;
- Su, Hongfei;
- Chen, Xing;
- Liu, Qiumeng;
- Li, Hui;
- Liang, Huifang;
- Chen, Xiaoping;
- He, Jiefeng;
- Ding, Zeyang;
- Zhang, Bixiang
Publication type:
Article
Central nervous system efficacy of aumolertinib versus gefitinib in patients with untreated, EGFR‐mutated, advanced non‐small cell lung cancer: data from a randomized phase III trial (AENEAS).
Published in:
Cancer Communications, 2024, v. 44, n. 9, p. 1005, doi. 10.1002/cac2.12594
By:
- Lu, Shun;
- Dong, Xiaorong;
- Jian, Hong;
- Chen, Jianhua;
- Chen, Gongyan;
- Sun, Yuping;
- Ji, Yinghua;
- Wang, Ziping;
- Shi, Jianhua;
- Lu, Junguo;
- Chen, Shaoshui;
- Lv, Dongqing;
- Zhang, Guojun;
- Liu, Chunling;
- Li, Juan;
- Yu, Xinmin;
- Lin, Zhong;
- Yu, Zhuang;
- Wang, Zhehai;
- Cui, Jiuwei
Publication type:
Article
Issue Information.
Published in:
Cancer Communications, 2024, v. 44, n. 9, p. 927, doi. 10.1002/cac2.12438
Publication type:
Article
Cellular senescence and metabolic reprogramming: Unraveling the intricate crosstalk in the immunosuppressive tumor microenvironment.
Published in:
Cancer Communications, 2024, v. 44, n. 9, p. 929, doi. 10.1002/cac2.12591
By:
- Zhang, Fusheng;
- Guo, Junchen;
- Yu, Shengmiao;
- Zheng, Youwei;
- Duan, Meiqi;
- Zhao, Liang;
- Wang, Yihan;
- Yang, Zhi;
- Jiang, Xiaofeng
Publication type:
Article